Bank Of New York Mellon Corp Surface Oncology, Inc. Transaction History

Bank Of New York Mellon Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.62 - $1.21 $82,083 - $160,195	132,393 New	132,393 $108,000
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.1 $2,453 - $4,907	-2,337 Reduced 1.28%	180,745 $187,000
Q2 2022 Aug 15, 2022	SELL	$1.42 - $3.15 $137,916 - $305,940	-97,124 Reduced 34.66%	183,082 $301,000
Q1 2022 May 11, 2022	BUY	$2.65 - $5.08 $6,269 - $12,019	2,366 Added 0.85%	280,206 $824,000
Q4 2021 Feb 11, 2022	BUY	$4.73 - $7.9 $242,649 - $405,270	51,300 Added 22.65%	277,840 $1.33 Million
Q3 2021 Nov 12, 2021	BUY	$5.16 - $7.98 $346,973 - $536,599	67,243 Added 42.21%	226,540 $1.72 Million
Q2 2021 Aug 11, 2021	BUY	$6.45 - $9.09 $530,628 - $747,816	82,268 Added 106.8%	159,297 $1.19 Million
Q1 2021 May 13, 2021	BUY	$7.25 - $13.82 $10,157 - $19,361	1,401 Added 1.85%	77,029 $600,000
Q4 2020 Feb 09, 2021	BUY	$6.87 - $10.48 $36,610 - $55,847	5,329 Added 7.58%	75,628 $698,000
Q3 2020 Nov 12, 2020	BUY	$5.06 - $7.23 $198,959 - $284,283	39,320 Added 126.92%	70,299 $485,000
Q3 2019 Nov 07, 2019	SELL	$1.4 - $2.84 $10,455 - $21,209	-7,468 Reduced 19.42%	30,979 $43,000
Q2 2019 Aug 12, 2019	SELL	$2.75 - $4.89 $58,951 - $104,826	-21,437 Reduced 35.8%	38,447 $108,000
Q1 2019 May 14, 2019	SELL	$4.11 - $5.88 $4,997 - $7,150	-1,216 Reduced 1.99%	59,884 $286,000
Q4 2018 Feb 11, 2019	BUY	$3.65 - $10.69 $167,571 - $490,777	45,910 Added 302.24%	61,100 $259,000
Q2 2018 Aug 06, 2018	BUY	$12.83 - $17.41 $194,887 - $264,457	15,190 New	15,190 $248,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.